Genetic Testing Reveals New Drug Targets in Esophageal Cancer
Study findings suggest a potential role for the use of targeted therapy in addition or as an alternative to conventional treatment in patients with esophageal cancer.
Read MoreSearch Results for: genetic testing
Assay Detects Targetable Cancer Driver
The quantitative polymerase chain reaction assay detects rearranged-during-transfection expression driven by chromosomal fusions regardless of the fusion partner.
Read MoreSignal Genetics and Moffitt Cancer Center Enter into Sponsored Research Agreement in Multiple Myeloma
Under a new agreement, Signal Genetics will perform testing on patient specimens to inform key patient management decisions, including the risk of progression from AMG disorders to symptomatic multiple myeloma.
Read More
Module Automates Sample Handling
Designed to minimize hands-on time and reduce the risk of cross contamination associated with manual sample handling, the module automates several processing steps.
Read MoreIOM Tackles Diagnostic Errors
Making the changes necessary to improve diagnostic processes will require a significant commitment of time and talent from professionals in the field.
Read More